Verteporfin photodynamic therapy for neovascular age-related macular degeneration: UK cohort study

Source: National Institute for Health Research Health Technology Assessment programme.
Area: News
Infusion of verteporfin followed by infrared laser exposure is called (verteporfin photodynamic therapy -VPDT), and is used to treat neovascular age-related macular degeneration (nAMD). The VPDT cohort study advised clinicians to follow patients every 3 months during treatment or active observation, retreating based on criteria used in the previous commercial 'TAP' (Treatment of Age-related macular degeneration with Photodynamic therapy) trials of VPDT.   The VPDT study aimed to answer five questions:   1. Is VPDT in the NHS provided (Read more...)

Full Story →